Summary
Global
Markets Direct's, 'CJ HealthCare Corp. - Product Pipeline Review - 2016',
provides an overview of the CJ HealthCare Corp.'s pharmaceutical research and
development focus.
The
report provides comprehensive information on the therapeutics under development
by CJ HealthCare Corp., complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of administration (RoA) and molecule
type. The report also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and the dormant and
discontinued projects.
Global
Markets Direct's report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases
from company/university sites and industry-specific third party sources. Drug
profiles featured in the report undergoes periodic review following a stringent
set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a real time basis.
Click Here For
Complete Report @ http://www.radiantinsights.com/research/cj-healthcare-corp-product-pipeline-review-2016
The
report helps in identifying and tracking emerging players in the market and
their portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.
Note*: Certain
sections in the report may be removed or altered based on the availability and
relevance of data.
Scope
-
The report provides a snapshot of the pipeline therapeutic landscape of CJ
HealthCare Corp.
-
The report provides overview of CJ HealthCare Corp. including its business
description, key facts, and locations and subsidiaries
-
The report features descriptive drug profiles for the pipeline products which
includes, product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
-
The report covers pipeline products based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
The report assesses CJ HealthCare Corp.'s pipeline therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and molecule
type
- The report features CJ HealthCare Corp.'s
out-licensed and partnered product portfolio and summarizes its dormant and
discontinued projects
Buy a Sample
copy of This Report @ http://www.radiantinsights.com/research/cj-healthcare-corp-product-pipeline-review-2016/request-sample
No comments:
Post a Comment